Rite Aid (RAD) intends to dispense the abortion pill in a "limited number" of its stores two weeks after competitors Walgreens Boots Alliance (WBA) and CVS Health (CVS) said they would get certified to provide the pill to patients, Bloomberg’s Fiona Rutherford reports. A company spokesperson said that Rite Aid seeks to sell the pill, mifepristone, to customers either in-person or by mail delivery in compliance with federal and state rules. "We are committed to ensuring equitable access to customers prescribed this product," the spokesperson said. Reference Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on RAD:
- Rite Aid ‘bears watching’ after CEO exit, Dealreporter says
- Unusually active option classes on open January 9th
- Rite Aid backs FY23 revenue view $23.7B-$24B, consensus $21.63B
- Rite Aid appoints Elizabeth Burr as interim CEO
- Short Report: Bears pounce on disappointing drug news from Gossamer and Verve